Philanthropy & Grantmaking
(T20Z)
IRS Verified
DX Registered
990 on File
PROSTATE CANCER FOUNDATION
Financial strength (30%)
68/100
Reliability (20%)
55/100
Effectiveness (25%)
85/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Mission Statement
The Prostate Cancer Foundation (PCF) funds the world’s most promising research to improve the prevention, detection, and treatment of prostate cancer and ultimately cure it for good.
Financial Overview — FY 2024
$56.7M
Total Revenue
$58.2M
Total Expenses
$46.5M
Net Assets
49
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
86.0%
Fundraising Efficiency
1226.1%
Operating Reserve
9.58x
Liability-to-Asset
56.1%
Revenue Diversification
95.3%
Executive Compensation
$3.2M
Compared with Peers
FY 2024
Compared with 923 similar organizations
(United States, Philanthropy & Grantmaking, $10M–$100M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
86.0% | 91.7% |
P10P90
|
Below median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
8.1% | 6.2% |
P10P90
|
Below median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
5.8% | 2.2% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
1226.1% | 925.3% |
P10P90
|
Below median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
9.6 mo | 70.2 mo |
P10P90
|
Bottom quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
56.1% | 2.5% |
P10P90
|
Bottom quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
95.3% | 88.2% |
P10P90
|
Below median |
|
Revenue growth
Year over year revenue growth
|
-1.1% | 17.6% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
5.5% | 10.6% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-2.6% | 6.3% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $56.7M | $58.2M | $46.5M | 86.0% | 49 |
| 2023 | $57.3M | $55.1M | $48.0M | 83.4% | 46 |
| 2022 | $71.9M | $61.5M | $45.4M | 82.2% | 42 |
| 2021 | $106.0M | $41.7M | N/A | — | 41 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.